These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1981927)

  • 21. Role of corticotropin-releasing hormone in stressor-induced alterations of sleep in rat.
    Chang FC; Opp MR
    Am J Physiol Regul Integr Comp Physiol; 2002 Aug; 283(2):R400-7. PubMed ID: 12121853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of tumor necrosis factor-alpha stimulated NFkappaB/p65 in human keratinocytes by alpha-melanocyte stimulating hormone and adrenocorticotropic hormone peptides.
    Moustafa M; Szabo M; Ghanem GE; Morandini R; Kemp EH; MacNeil S; Haycock JW
    J Invest Dermatol; 2002 Dec; 119(6):1244-53. PubMed ID: 12485424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liquid chromatography-mass spectrometry detection of corticotropin-releasing hormone and proopiomelanocortin-derived peptides in human skin.
    Slominski A; Szczesniewski A; Wortsman J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3582-8. PubMed ID: 11061505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adrenal regeneration in the rat is mediated by mitogenic N-terminal pro-opiomelanocortin peptides generated by changes in precursor processing in the anterior pituitary.
    Estivariz FE; Morano MI; Carino M; Jackson S; Lowry PJ
    J Endocrinol; 1988 Feb; 116(2):207-16. PubMed ID: 2832502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory effect of adrenocorticotropin on corticotropin- releasing factor release from rat hypothalamus in vitro.
    Suda T; Yajima F; Tomori N; Sumitomo T; Nakagami Y; Ushiyama T; Demura H; Shizume K
    Endocrinology; 1986 Jan; 118(1):459-61. PubMed ID: 3000747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement by proopiomelanocortin-derived peptides of growth hormone and prolactin secretion by bullfrog pituitary cells.
    Aida T; Yamamoto K; Kikuyama S
    Gen Comp Endocrinol; 1999 Jul; 115(1):101-9. PubMed ID: 10375468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Release of pro-opiomelanocortin-derived peptides from the pars intermedia and pars distalis of the rat pituitary: effect of corticotrophin-releasing factor and somatostatin.
    Kraicer J; Gajewski TC; Moor BC
    Neuroendocrinology; 1985 Nov; 41(5):363-73. PubMed ID: 2865690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stress-induced secretion of pro-opiomelanocortin-derived peptides in rats: relative importance of the anterior and intermediate pituitary lobes.
    Kjaer A; Knigge U; Bach FW; Warberg J
    Neuroendocrinology; 1995 Feb; 61(2):167-72. PubMed ID: 7753335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular cloning of proopiomelanocortin cDNA and multi-tissue mRNA expression in channel catfish.
    Karsi A; Waldbieser GC; Small BC; Liu Z; Wolters WR
    Gen Comp Endocrinol; 2004 Jul; 137(3):312-21. PubMed ID: 15201069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of adrenocorticotropin and other proopiomelanocortin-derived peptides on testosterone secretion by the in vitro perfused testis.
    Juniewicz PE; Keeney DS; Ewing LL
    Endocrinology; 1988 Mar; 122(3):891-8. PubMed ID: 2830098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bromocriptine-induced changes in the biochemistry, physiology, and histology of the intermediate lobe of the rat pituitary gland.
    Beaulieu M; Goldman ME; Miyazaki K; Frey EA; Eskay RL; Kebabian JW; Cote TE
    Endocrinology; 1984 May; 114(5):1871-84. PubMed ID: 6325134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ACTH-(4-10) through gamma-MSH: evidence for a new class of central autonomic nervous system-regulating peptides.
    Gruber KA; Callahan MF
    Am J Physiol; 1989 Oct; 257(4 Pt 2):R681-94. PubMed ID: 2552843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ACTH1-17 is a more potent agonist at the human MC1 receptor than alpha-MSH.
    Tsatmali M; Yukitake J; Thody AJ
    Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):1029-34. PubMed ID: 10644006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Release of melanotroph- and corticotroph-type proopiomelanocortin derivatives into blood after administration of corticotropin-releasing hormone in patients with septic shock without adrenocortical insufficiency.
    Matejec R; Löcke G; Mühling J; Harbach HW; Langefeld TW; Bödeker RH; Hempelmann G
    Shock; 2009 Jun; 31(6):553-60. PubMed ID: 18827746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 60 YEARS OF POMC: Purification and biological characterisation of melanotrophins and corticotrophins.
    Lowry P
    J Mol Endocrinol; 2016 May; 56(4):T1-T12. PubMed ID: 26643914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress.
    Slominski A; Wortsman J; Luger T; Paus R; Solomon S
    Physiol Rev; 2000 Jul; 80(3):979-1020. PubMed ID: 10893429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Melanin production through novel processing of proopiomelanocortin in the extracellular compartment of the auricular skin of C57BL/6 mice after UV-irradiation.
    Yamamoto H; Yamane T; Iguchi K; Tanaka K; Iddamalgoda A; Unno K; Hoshino M; Takeda A
    Sci Rep; 2015 Sep; 5():14579. PubMed ID: 26417724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRF, urotensin I, and sauvagine stimulate the release of POMC-derived peptides from goldfish neurointermediate lobe cells.
    Tran TN; Fryer JN; Lederis K; Vaudry H
    Gen Comp Endocrinol; 1990 Jun; 78(3):351-60. PubMed ID: 2161377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamic actions of corticotropin-releasing hormone and proopiomelanocortin derivatives in septic patients.
    Matejec R; Löcke G; Kayser F; Lichtenstern C; Weigand MA; Welters ID; Bödeker RH; Harbach HW
    J Cardiovasc Pharmacol; 2011 Jan; 57(1):94-102. PubMed ID: 20980919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Event-related brain potentials and working memory function in healthy humans after single-dose and prolonged intranasal administration of adrenocorticotropin 4-10 and desacetyl-alpha-melanocyte stimulating hormone.
    Smolnik R; Perras B; Molle M; Fehm HL; Born J
    J Clin Psychopharmacol; 2000 Aug; 20(4):445-54. PubMed ID: 10917406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.